GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
HONG KONG HIGHPOWER (HPJ) [hlAlert]

Rating:
Mkt Outperform
HPJ
up 55.31 %

HONG KONG HIGHPOWER (HPJ) rated Mkt Outperform with price target $4 by Rodman & Renshaw

Posted on: Friday,  May 13, 2011  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform HONG KONG HIGHPOWER (NASDAQ: HPJ) on 05/13/2011. Previously Rodman & Renshaw rated Mkt Outperform HONG KONG HIGHPOWER (NASDAQ:
HPJ) on 08/17/2009., when the stock price was $1.41. Since then, HONG KONG HIGHPOWER has gained 55.32% as of 09/17/2015's recent price of $2.19.
If you would have followed the previous Rodman & Renshaw's recommendation on HPJ, you would have gained 55.31% of your investment in 2222 days.

Hong Kong Highpower Technology, Inc. operates through its wholly owned subsidiary Hong Kong Highpower Technology Company Limited (HKHT) and its wholly owned subsidiaries Shenzhen Highpower Technology Co., Ltd. (Shenzhen Highpower), HZ Highpower Technology Co., Ltd. (HZ Highpower) and Springpower Technology (Shenzhen) Company Limited (formerly Sure Power Technology (Springpower). Through Shenzhen Highpower, the Company manufactures Nickel Metal Hydride (Ni-MH) rechargeable batteries for both consumer and industrial applications. During the year ended December 31, 2008, the Company commenced manufacturing Lithium-ion (Li-ion) rechargeable batteries through Springpower. The Company produces a line of batteries, falling into two categories: consumer batteries and industrial batteries. It produces A, AA and AAA sized batteries packing, as well as chargers and battery packs. Industrial batteries are designed for electric bikes, power tools and electric toys.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/13/2011 8:25 AM Buy
None
2.28 4.00
as of 12/30/2011
1 Week down  -5.76 %
1 Month down  -7.54 %
3 Months down  -24.03 %
1 YTD down  -70.21 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/31/2010 1:25 PM Buy
None
5.70 7.00
8/17/2009 8:25 AM Buy
None
1.41 5.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy